A detailed history of Lineweaver Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lineweaver Wealth Advisors, LLC holds 2,215 shares of LLY stock, worth $1.67 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
2,215
Previous 2,064 7.32%
Holding current value
$1.67 Million
Previous $1.87 Million 5.03%
% of portfolio
0.4%
Previous 0.41%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$772.14 - $960.02 $116,593 - $144,963
151 Added 7.32%
2,215 $1.96 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $34,068 - $42,724
-47 Reduced 2.23%
2,064 $1.87 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $36,124 - $48,329
61 Added 2.98%
2,111 $1.64 Million
Q4 2023

Jan 19, 2024

BUY
$525.19 - $619.13 $617,623 - $728,096
1,176 Added 134.55%
2,050 $1.19 Million
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $379,927 - $523,788
874 New
874 $469,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lineweaver Wealth Advisors, LLC Portfolio

Follow Lineweaver Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lineweaver Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lineweaver Wealth Advisors, LLC with notifications on news.